Showing results (21-30 of 298) with videos related to
Sort By:
Pageof 30
Hepatology (Baltimore, Md.)|April 20, 2017
Adult-onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entityChristopher Koh, Sasan Sakiani, Pallavi Surana, et al.Journal of Virology|March 16, 2004
Effects of mutations of the initiation nucleotides on hepatitis C virus RNA replication in the cellZhaohui Cai, T Jake Liang, Guangxiang LuoViruses|April 27, 2024
The Post-Transcriptional Regulatory Element of Hepatitis B Virus: From Discovery to TherapyKarim Mouzannar, Anne Schauer, T Jake LiangHepatology (Baltimore, Md.)|August 8, 2014
Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modelingJeremie Guedj, Yaron Rotman, Scott J Cotler, et al.Antiviral Research|May 25, 2019
Longitudinal effects of Nucleos(t)ide analogue therapy in chronic hepatitis B patients and the utility of non-invasive fibrosis markers during treatment: A single-center experience for up to 17 yearsPallavi Surana, Devika Kapuria, Carly Broadwell, et al.Gastroenterology|September 15, 2009
Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent mannerGolo Ahlenstiel, Rachel H Titerence, Christopher Koh, et al.Gastroenterology|March 15, 2006
The SH3 binding motif of HCV [corrected] NS5A protein interacts with Bin1 and is important for apoptosis and infectivitySantosh K Nanda, David Herion, T Jake LiangHepatology (Baltimore, Md.)|August 31, 2006
Hepatitis C virus entry: molecular biology and clinical implicationsHeidi Barth, T Jake Liang, Thomas F BaumertMethods in Molecular Biology (Clifton, N.J.)|July 23, 2024
Stem Cell-Derived Hepatocyte-Like Cells for Hepatitis B Virus InfectionYuchen Xia, Seung Bum Park, T Jake LiangAntiviral Chemistry & Chemotherapy|May 18, 2012
The application and mechanism of action of ribavirin in therapy of hepatitis CEmmanuel Thomas, Marc G Ghany, T Jake LiangPageof 30